Could a 1-Month pill course stop TB in schools?
NCT ID NCT06022146
First seen Jun 24, 2026 · Last updated Jul 15, 2026 · Updated 3 times
Summary
This study tests whether a 4-week course of two TB drugs works as well as the standard 3-month course to prevent active TB in students and staff who have been exposed. About 3,520 people from schools will take either the short or standard regimen. The goal is to see if the shorter option is easier to complete and just as effective.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- isoniazid and rifapentine
- What this could lead to
- If successful, this could offer a shorter, easier TB prevention option for teens and young adults, potentially increasing the number of people who complete treatment.
- What could go wrong
- This is a large phase 3 trial, but the shorter regimen may still cause side effects or be less effective than the standard 3-month course. Results may not apply outside school settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 3,520 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2023
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
13 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Aged ≥13 years and body weight ≥ 30 kg; 2. School-registered individuals including: * Currently attending junior / senior high school or university students; * School staff members; 3. Close contacts of active pulmonary TB index cases (confirmed or clinically diagnosed) within the school, defined by meeting both of the following: * Teachers/students sharing the same classroom or dormitory with the index case; * Exposure history: Prolonged sharing of enclosed space (\>4 hours total within 1 week) with the index case; 4. Confirmed LTBI status through screening; 5. Voluntary participation with signed informed consent form (for adults ≥18 years); 6. Parental / guardian consent and co-signed informed consent form (for minors aged 13-17 years). Exclusion Criteria: 1. Current active TB disease (clinically or bacteriologically confirmed); 2. Documented isoniazid/rifampicin resistance in the corresponding M. tuberculosis strain from the index case; 3. Self-reported use of rifamycins (e.g., rifampicin, rifapentine) or isoniazid for \>14 consecutive days within the past 2 years; 4. Prior completion of full-course of treatment for ATB or LTBI; 5. Hypersensitivity or intolerance to rifamycins (rifapentine / rifampicin) or isoniazid; 6. HIV positive serostatus or AIDS patients; 7. History of viral hepatitis (e.g., chronic hepatitis B, chronic hepatitis C) or liver cirrhosis; 8. Liver dysfunction (TBil\>2.5mg/dL \[43umol/L\] or ALT / AST\>2ULN) or renal dysfunction. 9. Current receiving immunosuppressive therapy or biological agents. 10. Hematologic disorders with either PLT\<50×109/L or WBC\<3.0×109/L. 11. Other conditions deemed unsuitable for TPT by investigators.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Latent tuberculosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
66 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
3rd People's Hospital of Bijie
RECRUITINGBijie, China
-
Chinese Medicine Hospital of Qingzhen
RECRUITINGGuiyang, China
-
Dalian Public Health Clinical Center
RECRUITINGDalian, Liaoning, China
-
First People's Hospital of Fuquan
RECRUITINGQiannan, Guizhou, China
-
First People's Hospital of Kaili
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
Guiyang Public Health Treatment Center
RECRUITINGGuiyang, Guizhou, China
-
Guizhou Aerospace Hospital
RECRUITINGZunyi, Guizhou, China
-
Huashan Hospital
RECRUITINGShanghai, Shanghai Municipality, 200040, China
-
Liuzhi Special District
RECRUITINGLiupanshui, Guizhou, China
-
People's Hospital of Baiyun District
RECRUITINGGuiyang, Guizhou, China
-
People's Hospital of Bozhou District
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Cengong
RECRUITINGQiandongnan Miao and Dong Autonomous Prefecture, Guizhou, China
-
People's Hospital of Changshun
RECRUITINGQiannan, China
-
People's Hospital of Chishui
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Congjiang
RECRUITINGQiandongnan Miao and Dong Autonomous Prefecture, Guizhou, China
-
People's Hospital of Dafang Town
RECRUITINGBijie, China
-
People's Hospital of Danzhai
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Daozhen Klau and Hmong autonomous county
RECRUITINGDaozhen Klau and Hmong Autonomous County in Zun'yi, Guizhou, China
-
People's Hospital of Fenggang
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Guanling
RECRUITINGAnshun, Guizhou, China
-
People's Hospital of Hezhang
RECRUITINGBijie, Guizhou, China
-
People's Hospital of Honghuagang District
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Huangping
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Huaxi District
RECRUITINGGuiyang, Guizhou, China
-
People's Hospital of Jianhe
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Jinping
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Kaiyang
RECRUITINGGuiyang, Guizhou, China
-
People's Hospital of Leishan
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Libo
RECRUITINGQiannan, Guizhou, China
-
People's Hospital of Liping
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Luodian
RECRUITINGQiannan, Guizhou, China
-
People's Hospital of Majiang
RECRUITINGQiandongnan Miao and Dong Autonomous Region, China
-
People's Hospital of Meitan
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Nayong
RECRUITINGBijie, China
-
People's Hospital of Panzhou
RECRUITINGLiupanshui, Guizhou, China
-
People's Hospital of Pingba District
RECRUITINGAnshun, Guizhou, China
-
People's Hospital of Puding
RECRUITINGAnshun, Guizhou, China
-
People's Hospital of Qianxi
RECRUITINGBijie, Guizhou, China
-
People's Hospital of Qianxi
RECRUITINGBijie, Guizhou, China
-
People's Hospital of Renhuai
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Rongjiang
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Sansui
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Shibing
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Shuicheng District, Liupanshui City
RECRUITINGLiupanshui, Guizhou, China
-
People's Hospital of Suiyang
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Taijiang
RECRUITINGQiandongnan Miao and Dong Autonomous Region, China
-
People's Hospital of Tianzhu
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Tongzi
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Wanshan District
RECRUITINGTongren, Guizhou, China
-
People's Hospital of Weining
RECRUITINGBijie, Guizhou, China
-
People's Hospital of Wuchuan Klau and Hmong autonomous county
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Wudang District
RECRUITINGGuiyang, Guizhou, China
-
People's Hospital of Xifeng
RECRUITINGGuiyang, Guizhou, China
-
People's Hospital of Xishui
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Xiuwen
RECRUITINGGuiyang, Guizhou, China
-
People's Hospital of Xixiu District
RECRUITINGAnshun, Guizhou, China
-
People's Hospital of Yuqing
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Zhengan
RECRUITINGZunyi, Guizhou, China
-
People's Hospital of Zhenning
RECRUITINGAnshun, Guizhou, China
-
People's Hospital of Zhenyuan
RECRUITINGQiandongnan Miao and Dong Autonomous Region, Guizhou, China
-
People's Hospital of Zhijin
RECRUITINGBijie, Guizhou, China
-
People's Hospital of Ziyun
RECRUITINGAnshun, Guiyang, China
-
Second People's Hospital of Liupanshui City
RECRUITINGLiupanshui, Guizhou, China
-
Third People's Hospital of Liupanshui
RECRUITINGLiupanshui, Guizhou, China
-
Zunyi Infectious Disease Hospital
RECRUITINGZunyi, Guizhou, China
-
Zunyi Infectious Disease Hospital
RECRUITINGZunyi, Guizhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Once-Daily HIV pill with food match Twice-Daily dosing during TB treatment?
- Can simple sputum and urine tests catch tuberculosis earlier?
- Can a common virus be turned into a TB vaccine? scientists test VIR-1778
- Fish oil meets TB drugs: can Omega-3 help clear infection faster?
- Can starting TB treatment immediately save lives in HIV sepsis?
- Can a 4-Drug combo cut TB treatment time in half?